ACTU
ACTUATE THERAPEUTICS
πΊπΈ NYSE/NASDAQ
π Overview
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-10.54%
Growth
1 months growth
π
0
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Actuate Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases. The Company focuses on the development of compounds for combination use in carcinomas, including glioblastoma, ovarian, breast and pancreatic cancers. Its lead compound, 9-ING-41, is in preclinical xenograft models of cancers, including both drug sensitive and drug resistant carcinomas.
π Performance
Price History*
-1.11%
1M
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
0%
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$7.31
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in ACTU
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in ACTU
N/A
ACTU investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in ACTU also invest in...
Want more shares? Try these...
π Performance (5Yr p.a)
22.21%
π Share price
$42.10 USD
π HIGH PRICE GROWTH
π Performance (5Yr p.a)
13.68%
π Share price
$4.58 USD
π HIGH PRICE GROWTH